James L. Poth

For more than two decades, Jim Poth has assisted hospitals, health systems, laboratories, and other health care providers in implementing and executing strategies to ensure they receive appropriate reimbursement. His practice has focused on representing health care providers in litigation, arbitration, and negotiations with all types of payors. He has been the lead trial lawyer … Read more

Gregory M. Luce

Mr. Luce focuses on the counseling and defense of health care providers, suppliers, pharmaceutical companies and physicians under state and federal fraud and abuse laws and the False Claims Act, as well as on the design and implementation of compliance programs. In addition, he represents numerous health care providers and corporations in response to civil … Read more

Alan B. Leeds

Leader of the firm’s life sciences transactions practice and a co-leader of the firm’s global life sciences industry initiative, Alan B. Leeds represents life sciences companies from early-stage biotechnology startups to global pharmaceutical companies, as well as specialty pharma, medical device, and other technology companies. He also works with venture capital firms that focus on … Read more

Merton G. Gollaher

Merton G. Gollaher combines life-science experience with a talent for deal-making to help health care and technology clients compete in ever-changing markets. Trained as a chemist and with years of research experience as a molecular geneticist, Mr. Gollaher utilizes strong analytical thinking to resolve his client’s concerns and help build new affiliations, structure novel delivery … Read more

Dimitrios Drivas

Partner in the Firm’s Global Intellectual Property Practice Group, Dimitrios’ practice focuses on patent litigation and counselling, and technology transfer. A registered US patent attorney, clients benefit from his representation in complex patent and technology-related disputes in the Patent Office, courts and before arbitration panels. His extensive practice experience, which spans a period of 30 … Read more

Jennifer L. Bragg

Since serving in the FDA’s Office of Chief Counsel as associate chief counsel for enforcement, Ms. Bragg has represented companies in criminal and civil litigation and strategic regulatory matters. She is frequently called upon to conduct due diligence and related counseling in connection with transactions in the life sciences and health care industries, and has … Read more